during hospital admission, 11 worse functional outcomes, 9 longer length of hospitalization, 5, 7, 10, 12, 13 and higher hospital costs. 14 There is an extensive amount of research on the early outcome of SAP;
however, it remains unclear whether or not the increased mortality risk persists after 1 year due to heterogeneity of these studies and lack of long-term follow-up. 2 It is well recognized that acute stroke induces both the central nervous system (CNS) and peripheral inflammatory responses.
Indeed, peripheral inflammatory markers are persistently elevated after stroke (to at least 3 months) compared to non-stroke controls and are exacerbated by infectious complications. 15, 16 Peripheral inflammatory markers in the acute phase of stroke are associated with worse functional outcome, survival, and recurrent vascular events in the interim and longer term. 17 SAP, by augmenting acute and longerterm inflammatory responses, complicating stroke might therefore plausibly contribute to longer-term outcome after stroke.
We hypothesized that SAP has adverse effects on longer-term outcomes compared to non-SAP. The main aim of this study therefore was to investigate the association between SAP and adverse outcomes including mortality at different predefined time periods:
short (inpatient and 90 days), medium (91 days-1 year), and long
(1-3 years and 3-10 years) terms. We also aimed at evaluating the effect of SAP on the length of hospital stay and functional outcome at discharge. Our secondary aim was to explore the association between different types of SAP, namely aspiration and non-aspiration pneumonia based on clinicians' diagnosis.
| MATERIAL S AND ME THODS

| Study participants and design
Of 11 886 entries on the stroke register, 9238 patients with acute stroke who were admitted between 2003 and 2015 were included in the study. Figure S1 details the reasons for exclusion. Baseline demographic and clinical data of study participants were extracted from the comprehensive stroke and TIA register of a tertiary regional stroke center, and ethical approval was granted by the Newcastle and Tyneside National Health Service (NHS) Research Ethics Committee (12/NE/0170).
All acute stroke cases were verified by stroke physicians based on clinical features and CT/MRI imaging. SAP was defined as pneumonia diagnosed on admission or within the first 7 days of admission after stroke onset. 18 Information on the incidence of SAP (aspiration or non-aspiration) was retrieved from the hospital's Patient Administration System (PAS), reviewed and identified with codes in the 10th revision of the International Classification of Disease (ICD-10), based on previously employed methods. [19] [20] [21] [22] The diagnosis of pneumonia was made by clinicians during the hospital stay based on signs and symptoms suggestive of acute lower respiratory tract infection based on British Thoracic Society (BTS) guidelines and previous studies. 19 Further classification into aspiration and nonaspiration pneumonia was made by the clinician based on distinguishing features such as dysphagia status, nil by mouth and location of shadowing on chest X-ray; however, the accuracy may be limited by the lack of validated criteria for diagnosing aspiration pneumonia. 22 The following diagnosis codes classified as SAP in the current study-J69: aspiration pneumonia and non-aspiration pneumonia, 
| Study outcomes
The outcomes of interest were (i) mortality-short-term mortality (inpatient and 90 days), medium (91 days-1 year), and long-term mortality (1-3 years and 3-10 years post-stroke); (ii) long length of stay (LOS), defined as >14 days; and (iii) functional outcome depicted by the modified Rankin Scale (mRS) score at discharge. The outcome was dichotomized as good (0-2) and poor (3) (4) (5) (6) . 23 Linkage with the Office of National Statistics (ONS) for mortality data ensures nearcomplete follow-up for this outcome. Biochemical and hematological measurements relevant to acute inflammatory response including total white cell count (WCC) and C-reactive protein (CRP) were collected on hospital admission.
| Potentially confounding covariates
| Statistical analysis
All analyses were agreed a priori to avoid biased post hoc decisions. 
| RE SULTS
The prevalence of SAP was 11.7% (n = 1083). The mean age (SD) was 77.61 ± 11.88 years, with 47.5% of males and 87.0% having had ischemic stroke. 77.1% cases of pneumonia were diagnosed on the same day of hospital admission, and crude inpatient mortality was 21.3% in those with SAP. Table 1 Table 2 shows the mortality outcome during different time periods. The highest mortality following stroke was observed between 0 and 90 days, while the risk of mortality was at its lowest after 3 years.
The cumulative mortality was significantly greater for patients with SAP, particularly in those diagnosed with aspiration pneumonia.
Figures S2 and S3 shows KM cumulative survival by pneumonia status and type for the overall stroke cohort. The curve plateaus after approximately 1 year for those with SAP, indicating that the excess/ increased risk of mortality persists for 1 year in patients with SAP, after which SAP patients have a similar, then lower mortality rate compared to those without pneumonia beyond 3 years. Figure S4 shows that SAP conferred higher odds of inpatient and 0-to 90-day mortality in patients diagnosed with aspiration pneumonia (OR 1.54 and HR 1.29, respectively) compared to those diagnosed with non-aspiration pneumonia (P < .005). They were also more likely to be associated with worse functional outcome (95.7% vs 88.7%, P < .001), but the length of hospitalization was not significantly different. A log-rank test for equality of survival functions showed a large difference between the different groups over 10 years of follow-up (P < .001). The functional outcomes at discharge were available for 6013 
| D ISCUSS I ON
Our results confirm that SAP adversely affects mortality up to 1 year and is associated with prolonged hospitalization and poor functional status at discharge in patients after stroke, even after adjustment for various established prognostic factors. We further established that patients diagnosed with aspiration pneumonia have a higher shortterm mortality compared to patients diagnosed with non-aspiration pneumonia.
Stroke-associated pneumonia is arguably a preventable complication, which warrants increased efforts to identify those at risk and develop interventions to reduce incident cases given the impact of pneumonia on poor outcomes. To our knowledge, this is the first study analyzing the effect of SAP on mortality risk up to 10 years of follow-up. The existing literature either did not examine the mortality in specified time period or only took into account outcomes that developed early within 7 days to 3 months after stroke. 7, 9 Our longterm follow-up using consecutively admitted patient information enables us to provide novel insights into the longer-term prognosis of SAP.
The overall frequency of SAP was 11.7%, corroborating results observed in previous studies. 9, 21, 24 Patients with SAP were older, more likely to have a diagnosis of TACS, had a higher prestroke mRS, and had more additional comorbidities and higher inflammatory markers. These findings, in line with previous studies, that patients with SAP have a higher severity of disease, medical complexity, and frailty. We found that 77.1% of patients with SAP were diagnosed on the day of admission. This figure is higher than that reported in the literature, that is 40%-68%. 6, 21, 25 This discrepancy may be explained by marked heterogeneity between studies,
influenced by factors such as study population, environment, and approach to diagnosis. 1 Our higher rate of pickup may also be due to the presence of a hyperacute bay with constant physiological monitoring which may benefit from more rigorous detection of infection. However, the early diagnosis of SAP in our study did not translate into better outcomes which may be explained by the lack of efficacy of prophylactic antibiotics given within 24 and 48 hours of stroke onset as shown in 2 recent trials. 26, 27 It has been proposed that administration of preventative antibiotics in these trials may in fact have been too late to prevent SAP and that the results are limited by the heterogeneity of antibiotic choice. 28 This necessitates a paradigm shift to initiate preventative interventions, for those at risk of SAP, in the hyperacute phase (under 24 hours) of stroke in future large clinical trials.
There is a substantial variation in terms of the reported mortality rate across different studies. 5, 6, 8, 12, 13, 29 The overall mortality rates in this study were slightly higher than previous studies, with 61.5%
at discharge and 73.6% at 1 year (Table 2) . Notably, we observed excess mortality from SAP even among those surviving up to 1 year following hospitalization. This was accompanied by a plateau and reduction in mortality risk after 3 years. Although this observation has not been previously described, several mechanisms have been proposed to explain this effect. This finding could be influenced by the small number of patients with SAP who survived beyond 3 years.
Alternatively, we may be limited by residual confounding. Despite robust covariate adjustments in our study, it is possible that better prognosis after 3 years in participants with SAP could be attributable to other factors that were not accounted for in our analyses, such as newly developing chronic comorbid disease impacting on mortality. While the overall sample size is reasonable between 3 and 10 years (n = 5223), only 208 patients with SAP have survived up to 3 years, suggesting that most who will die as a result of SAP would have died within the first 3 years after stroke. This may also be because of the significantly higher age of patients with SAP, resulting in earlier death (before 3 years) due to age-related factors compared to patients without SAP. Furthermore, it is also possible that the severity of SAP they had was mild, leading to lower risk in later time periods. It is probable that non-SAP group is catching up with mortality as those who survived beyond 3 years have higher comorbid burden with time and associated increased frailty which
were not accounted for in the analysis.
One study used survival analyses to examine the long-term impact of the medical complications in stroke patients beyond 1 year. 24 It was shown that cumulative mortality continued to rise over the entire follow-up period (4 years), never reaching a plateau. The authors highlighted that the excess risk of death following medical complication never abated, suggesting that the characteristics of the population were responsible rather than the insults of the complication episode. The findings of the present study are an initial observation, and whether this represents the true impact of SAP on long-term outcomes needs to be further tested in different populations.
Traditionally, SAP has been thought to be aspiration-related secondary to dysphagia. However, recent studies have shown that up to half of the patients who develop pneumonia after stroke do not aspirate, which implies that not all SAP is aspiration-related. 6 In line with the published literature, 20, 30 we observed differences in the characteristics and outcomes between the diagnoses of aspiration and non-aspiration pneumonia. Those diagnosed with aspiration pneumonia were more likely to have higher short-term mortality and poor functional outcome compared to those with non-aspiration pneumonia. Patients with aspiration pneumonia had a significantly higher proportion of TACS compared to non-aspiration pneumonia when tested for statistical significance individually, and this may reflect higher severity of disease in those diagnosed with aspiration pneumonia. We controlled for stroke type, stroke severity, and a wide range of confounding factors in our multivariable analyses. Therefore, outcomes are likely due to the type of pneumonia. However, we acknowledge that we were limited by the lack of dysphagia status in patients. For stroke patients truly experiencing aspiration, the pathophysiological basis for poorer outcomes can be OCSP, Oxfordshire Community Stroke Project classification; LACS, Lacunar stroke; PACS, partial anterior circulation stroke; POCS, posterior circulation stroke; TACS, total anterior circulation stroke; TIA, transient ischemic attack; CHD/MI, coronary heart disease/myocardial infarction; AF, atrial fibrillation; CHF, congestive heart failure; PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease. Categorical data are presented as frequency counts (%), and continuous data such as WCC and CRP are presented as median (IQR). a Subgroup analysis, n = 7425, a total of 1813 cases were not included in the analysis of WCC and CRP due to missing data. b Subgroup analysis, n = 1023, a total of 60 cases were not included in the analysis due to missing WCC and CRP.
TA B L E 1 (Continued) explained by the presence of oropharyngeal or gastric contents in the airway which can result in a higher severity of epithelial disruption, impaired gas exchange, and prolonged healing than when the airway is exposed to exogenous bacteria alone. 31, 32 However, the accuracy of categorizing aspiration and nonaspiration pneumonia by hospital clinicians is not within the scope of this study, and the retrospective nature of this study does not allow verification of the accuracy of the type of pneumonia diagnosis. The difficulties in studying aspiration pneumonia are well recognized throughout the literature due to the lack of a sensitive and specific marker for aspiration pneumonia, as well as the potential overlap of clinical signs and symptoms between aspiration pneumonia and other forms of pneumonia. 33 Although we categorized SAP into aspiration and non-aspiration subtypes based on the available clinical and investigation data for the analyses, we acknowledge that accurately discriminating these subtypes in clinical practice is challenging and the prognostic value is uncertain.
Our study has several strengths. The nature of our study with a long follow-up period enabled us to provide more robust prognostic information on the long-term impact of SAP. This study is also unique in having a large and well-defined stroke population that is representative of the real-world stroke population, all of whom had relevant measurements of disease at baseline and were followed up prospectively until death or the end of study period. The availability of these data allowed us to adjust for many potential confounders in our analysis including inflammatory markers which are important determinants of stroke outcome. 15 Our study has several limitations in addition to those described earlier. The clinical severity of pneumonia was not accounted for in this study, and misclassification of pneumonia type is a possibility due to the lack of a "gold standard" for the diagnosis of aspiration pneumonia. We had to rely on the clinician's best judgment to determine whether the mechanism of pneumonia was aspiration or non-aspiration and this carries a margin of error. 34 However, the data The inpatient mortality and odds of long length of hospital stay are derived from binary logistic regression models. The 90-, 365-, and 1095-day mortality hazard ratios are analyzed by Cox regression models. Long length of hospital stay is defined as hospital stay of more than 14 days since the day of admission. came from a single unit with yearly patient flow of approximately 1000 per annum stroke cases looked after by a single stroke team with 3-5 consultants during the study period. The shift system within the NHS suggests that most patients were looked after by more than one consultant in each hospital episode, and hence, any disagreement in diagnosis would have been resolved with final coding verified. The discharge mRS scores were only available in 65.1% of the population, which could have led to the underestimation of the functional outcome. Nevertheless, the internal relationship between SAP and outcome is unlikely to be different. Finally, data to assess the severity of stroke impairment such as the National Institute of Health Stroke Scale (NIHSS) were not available. However, we adjusted for OCSP classification and prestroke mRS, which has been shown to be indicative of major determinants of mortality in stroke. 35 We found that SAP was not associated with poorer long-term outcomes. However, our findings that SAP is significantly associated with higher mortality up to 1 year, longer hospitalization, and worse functional outcome highlight the importance of early identification and treatment of SAP. Future efforts should aim to develop better ways of identifying stroke patients at high risk of aspiration and pneumonia and on strategies to prevent this complication.
TA B L E 2 Mortality of patients at different time periods
ACK N OWLED G EM ENT
We thank the data team of the Norfolk and Norwich University Hospital Stroke Services.
CO NTR I B UTO R S
PKM and CJS conceived the study. WHT performed the literature search and analyzed the data under supervision of RSB, ADW, and ABC. JHBS was responsible for data management. PKM is the principal investigator, and AKM, KMB, and JFP are co-principal investigators of the NNUH Stroke Register. WHT drafted the draft version of the manuscript, and all authors contributed to the manuscript. PKM is the guarantor of the content of the manuscript, including the data and analysis. 
CO N FLI C T O F I NTE R E S T
R E FE R E N C E S
